At Lonza, we are at the forefront of supporting the development of emerging therapies.

The cell and gene therapy market is expanding rapidly. It promises significant long-term health benefits to people suffering from a wide range of diseases, from ophthalmological disorders to cancer.

Search open roles and start your journey today​​

Who are we?

We are one of the largest teams in the industry. With our scale and opportunities, ours is a company like no other.

Our competitive advantage lies in the combination of products, tools and an integrated offering beyond manufacturing, with unmatched process development expertise and industrialization capabilities.

Our Services

We take living cells and viruses; isolating, reproducing and characterizing them to deliver cutting-edge therapies on a global scale.

Our offering spans products and services for allogeneic and autologous cell therapies, as well as viral vector gene therapies.

Together, these services provide an end-to-end offering from concept to commercialization. We are building industry standards, so this is your chance to have a profound impact.

Years of Cell and Gene cGMP manufacturing experience
Pre-clinical therapies supported by Bioscience
Clinical and commercial therapies supported by Bioscience
Process development projects

Cell & Gene Manufacturing Footprint

This has images This has images This has images

Hear from our people